NYSE - Nasdaq Real Time Price • USD
Tenet Healthcare Corporation (THC)
As of 2:20 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jul 2023) | Next Qtr. (Oct 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jul 2023) | Next Qtr. (Oct 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 9.12M | -- |
| Low Estimate | -- | -- | 9.12M | -- |
| High Estimate | -- | -- | 9.12M | -- |
| Year Ago Sales | 897k | -- | 3.34M | 9.12M |
| Sales Growth (year/est) | -- | -- | 173.10% | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jul 2023) | Next Qtr. (Oct 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0.01 | 0 |
| 30 Days Ago | 0 | 0 | 0.01 | 0 |
| 60 Days Ago | 0 | 0 | 0.01 | 0 |
| 90 Days Ago | 0 | 0 | 0.01 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jul 2023) | Next Qtr. (Oct 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | THC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.80% |
| Next Qtr. | -- | -- | -- | 9.60% |
| Current Year | -- | -- | -- | 4.50% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Upgrades & Downgrades
| Maintains | Deutsche Bank: Buy to Buy | 4/12/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/10/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/28/2024 |
| Upgrade | Wolfe Research: Peer Perform to Outperform | 3/27/2024 |
| Maintains | Mizuho: Buy to Buy | 3/11/2024 |
| Initiated | Barclays: Overweight | 3/6/2024 |
Related Tickers
CYH Community Health Systems, Inc.
2.8400
+2.16%
UHS Universal Health Services, Inc.
156.63
+1.94%
HCA HCA Healthcare, Inc.
305.62
+2.90%
SGRY Surgery Partners, Inc.
24.04
+2.63%
ACHC Acadia Healthcare Company, Inc.
70.23
-0.07%
DVA DaVita Inc.
127.85
+1.38%
OPCH Option Care Health, Inc.
30.75
-0.49%
SEM Select Medical Holdings Corporation
27.04
+2.29%
EHC Encompass Health Corporation
79.30
+0.87%
USPH U.S. Physical Therapy, Inc.
98.69
+1.23%